trial

Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training

NCTId NCT05956327
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 156 (estimated)
Sponsored by LMU Klinikum
Primary completion 2026-09
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
156 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2023-09-29
Primary completion
2026-09
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Aerobic Endurance TrainingFlexibility, strengthening and balance training

Sponsors

LMU KlinikumLead Sponsor
German Research FoundationCollaborator

Investigators

1
Peter G. Falkai, Prof. Dr.Principal Investigator

Sites

1 total
Munich, Germany

Facts & assertions

4 sourced
Enrollment
156
Phase
NA
Primary Completion Date
2026-09
Status
RECRUITING
relationships
The graph out of here
drug
Aerobic Endurance Training
drug
Flexibility, strengthening and balance training
drug
lead_sponsor
LMU Klinikum
company
collaborator
German Research Foundation
company
indication
Neuronal Plasticity
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Peter G. Falkai, Prof. Dr.
person